Evidence of IL6 expression in the tumor stroma of primary ES and dismal prognosis of patients presenting with higher IL6 levels at diagnosis further suggest a biological relevance of this cytokine in ES pathogenesis. This evidence concerns the gene IL6 and neoplasm.